Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China
· Delayed Price · Currency is CNY 6.02
-0.19 (-3.06%)
Apr 25, 2025, 3:04 PM CST
SHE:002550 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 24, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 7,524 | 7,749 | 7,525 | 8,012 | 6,181 | 5,439 | Upgrade
|
| Market Cap Growth | 15.52% | 2.97% | -6.07% | 29.61% | 13.64% | -7.21% | Upgrade
|
| Enterprise Value | 6,697 | 7,071 | 7,054 | 7,508 | 5,582 | 4,818 | Upgrade
|
| Last Close Price | 6.02 | 6.20 | 5.76 | 6.00 | 4.53 | 3.87 | Upgrade
|
| PE Ratio | 18.51 | 21.76 | 41.38 | 24.77 | 34.14 | - | Upgrade
|
| Forward PE | 20.07 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | Upgrade
|
| PS Ratio | 4.96 | 5.08 | 4.15 | 3.48 | 3.30 | 3.26 | Upgrade
|
| PB Ratio | 2.81 | 3.08 | 3.04 | 3.29 | 2.92 | 2.63 | Upgrade
|
| P/TBV Ratio | 2.94 | 3.23 | 3.23 | 3.43 | 3.08 | 2.78 | Upgrade
|
| P/FCF Ratio | 24.16 | 18.27 | 17.38 | - | 468.80 | 21.35 | Upgrade
|
| P/OCF Ratio | 18.12 | 15.06 | 14.11 | - | 59.69 | 17.14 | Upgrade
|
| EV/Sales Ratio | 4.42 | 4.63 | 3.89 | 3.26 | 2.98 | 2.89 | Upgrade
|
| EV/EBITDA Ratio | 18.15 | 19.64 | 31.86 | 26.13 | 25.17 | 17.19 | Upgrade
|
| EV/EBIT Ratio | 22.03 | 24.01 | 45.73 | 33.74 | 36.63 | 22.94 | Upgrade
|
| EV/FCF Ratio | 21.51 | 16.68 | 16.29 | - | 423.36 | 18.91 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.04 | 0.04 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.05 | 0.06 | 0.25 | 0.36 | 0.42 | 0.15 | Upgrade
|
| Debt / FCF Ratio | 0.06 | 0.05 | 0.13 | - | 7.10 | 0.16 | Upgrade
|
| Asset Turnover | 0.53 | 0.55 | 0.65 | 0.87 | 0.76 | 0.62 | Upgrade
|
| Inventory Turnover | 1.57 | 1.34 | 1.84 | 3.03 | 2.92 | 3.13 | Upgrade
|
| Quick Ratio | 6.65 | 4.53 | 4.89 | 4.00 | 3.83 | 4.18 | Upgrade
|
| Current Ratio | 10.22 | 7.58 | 7.90 | 6.07 | 5.30 | 5.35 | Upgrade
|
| Return on Equity (ROE) | 15.25% | 13.35% | 7.28% | 14.06% | 8.91% | -6.71% | Upgrade
|
| Return on Assets (ROA) | 6.69% | 6.58% | 3.46% | 5.24% | 3.84% | 4.87% | Upgrade
|
| Return on Capital (ROIC) | 7.33% | 7.27% | 3.81% | 5.86% | 4.41% | 5.49% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.00% | 11.30% | 6.00% | 8.80% | 6.90% | 9.70% | Upgrade
|
| Earnings Yield | 5.49% | 4.59% | 2.42% | 4.04% | 2.93% | -2.43% | Upgrade
|
| FCF Yield | 4.14% | 5.47% | 5.75% | -1.78% | 0.21% | 4.68% | Upgrade
|
| Dividend Yield | 1.93% | - | 2.08% | 2.00% | 2.65% | 3.10% | Upgrade
|
| Payout Ratio | 36.81% | 42.56% | 87.31% | 47.98% | 83.67% | - | Upgrade
|
| Buyback Yield / Dilution | 1.91% | 2.11% | -0.41% | -7.16% | -0.58% | 4.01% | Upgrade
|
| Total Shareholder Return | 3.84% | 2.11% | 1.67% | -5.16% | 2.07% | 7.11% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.